News Nokia exec says no future for digital health unit - report Memo adds to speculation Nokia could close digital health business
News Immunotherapy arms race latest: Merck buys Viralytics for $3... Big pharma pays 160% premium for Australian biotech
News Lilly axes trial of Hanmi's arthritis drug Lilly may decide to develop drug in other indications
News AZ signs kidney drug deal with Ionis for up to $330m Deal is result of six-year collaboration with AZ
News Roche to buy health records firm Flatiron for $1.9bn Flatiron has backers including Google parent Alphabet
News Concerns mount over Biogen Alzheimer's drug FDA announces guidance to encourage development of new drugs
News Sanofi abandons phase 3 trial of neurology drug riliprubart Sanofi's neurology pipeline has had a hole blown in it after a phase 3 trial of riliprubart in rare disease CIDP was stopped for futility.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
